Occurrence of NHL in HIV-infected patients has been initially attributed to the state of immunodeficiency, as observed in patients with primary immunodeficiency or after organ tran~plantation.'~,'~ Posttransplant lymphomas have been proposed to be the consequence of the uncontrolled proliferation of EBV-infected cells giving rise to proliferations of extremely variable m~r p h o l o g y . '~'~ Large-cell lymphomas of the immunoblastic type are particularly frequent in cardiac transplant recipients." Lymphoproliferations in Several studies have pointed out the different characteristics of these two types of lymphomas in the context of HIV infection. Immunoblastic lymphoma (IL) and large-cell lymphomas occur usually in patients with severe immunodeficiency with an extremely low count of CD4' lymphocytes. These tumors do not respond to chemotherapy and have a poor progn~sis.~ In contrast, BL generally occurs in patients with less severe immunodeficiency, is often preceded by a generalized reactive lymphadenopathy, and responds better, at least initially, to chemotherapy.'~~ Previous studies on the presence of EBV in BL among HIV camers have described a viral association in about one-half of the cases. For personal use only. on October 30, 2017. by guest www.bloodjournal.org From
However, in addition to immunoblastic lymphomas, HIV carriers have also a high risk of small noncleaved cell lymphomas principally of the Burkitt type (BL), a complication only exceptionally identified to date in congenital or acquired immunodeficiencies other than acquired immunodeficiency syndrome (AIDS).'s3 BL is characterized by its monoclonality and one of the typical t(8;14), t(2;8), or t (8;22) translocations affecting the c-myc locus. However, association with EBV is not a constant f e a t~r e .~~.~~ Several studies have pointed out the different characteristics of these two types of lymphomas in the context of HIV infection. Immunoblastic lymphoma (IL) and large-cell lymphomas occur usually in patients with severe immunodeficiency with an extremely low count of CD4' lymphocytes. These tumors do not respond to chemotherapy and have a poor progn~sis.~ In contrast, BL generally occurs in patients with less severe immunodeficiency, is often preceded by a generalized reactive lymphadenopathy, and responds better, at least initially, to chemotherapy.'~~ Previous studies on the presence of EBV in BL among HIV camers have described a viral association in about one-half of the cases. 
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MATERIALS AND METHODS
Pathologic Samples
Tumoral biopsies obtained from patients infected by HIV were used for simultaneous morphologic and molecular analyses. Cases with partial tumoral infiltration were systematically excluded from our study. Tumors from 14 patients satisfied the conditions cited above.
Part of material was formalin-fixed and embedded after standard procedures. DNA was extracted from the rest of the primary material, with the exception of case 1 and 2 where in vitro cultured cell lines established from the initial tumors were used (IARC BL 1 15 and IARC BL 134).
These tumors were diagnosed and classified, according to the international working formulation (Table I ). All pathologic findings, except cases 1 and 2, were reviewed by the members of the "French Study Group of Pathology for HIV-Associated Tumors." Cases I and 2 were diagnosed and typed in Lyon (Centre U o n BCrard).
DNA Isolation and Southern Blotting
Total cellular and viral DNA was prepared by sodium dodecyl sulfate (SDS) cell lysis, proteinase K digestion, phenol/chloroform extraction, and ethanol precipitation.
Ten micrograms of DNA were digested with 50 IU of the appropriate endonucleases (Bethesda Research Laboratories, Bethesda, MD).
Digested DNAs were electrophoresed on a 0.7% to 0.9% agarose gel in TBE (0.045 mol/L Tris-Borate 0.00 1 mol/L EDTA) buffer, hydrolyzed for 15 minutes in 0.25 N HCl, denatured for 30 minutes, and renatured before being transferred onto Hybond N filter (Amersham, Amersham, UK) according to Southern analysis. Probes were labeled with 32P by multiple random priming (Amersham) and hybridized with the filter at 65" in 0.5 mol/L NaH,PO,, pH 7.2, 1% bovine serum albumin (BSA), 7% SDS.
Filters were washed at 60°C for 30 minutes in 2X SSC, 0.1 % SDS, for 15 to 30 minutes in 0.2X SSC (0.15 mol/L NaCI, 0.01 57 sodium citrate), 0.1% SDS, and autoradiographed using intensifying screens (Quanta III; Dupont, Wilmington, DE).
DNA Probes
Rearrangements of the c-myc gene were studied by hybridization of BamHI-, EcoRI-, HindIII-, or Xba I-digested DNAs to probes representative of the first or third exon of the c-mycgene'* (Fig IA) . Rearrangements 3' of c-myc in pvt-1 or bvr-1 regions were analyzed using the probes 455 and 550. 39 These genomic probes represent parts of the bvr-1 and pvt-l loci, respectively situated 140 and 260 kb 3' of the c-myc locus, which are frequently involved in the t(2;8) and t(8;22) variant translocations3941 (Fig. 1A) . The search for rearrangements 5' of c-myc was performed using the probe p380j9 0.8 SS (kindly provided by F. Haluska) situated at 175 kb 5' of cmy^.",^'
The organization of the IgH locus was analyzed by hybridization of BamHI-, EcoRI-, HindIII-and Xba I-digested DNA to probes specific ofthe joining region (JH) and of the Cp gene (Fig IB) . The K light chain was studied using a 2-kb J K and a 2.5-kb C K fragment.
Search for EBV DNA was done using a probe specific for the BamHI-W internal repeats of the vin1s,4~ and the 1.9-kb Xho I fragment located near the right end of the linear viral genome:' Table 1 summarizes the main clinical and pathologic characteristics of our cases. Fourteen tumor samples were collected in four French hospitals (Hbpital Pitit-Salp&ri2re, Paris; Hbpital Beaujon, Paris; Hbpital d'Argenteui1; Centre Lton Btrard, Lyon). Seven patients were homosexual, four were heterosexual with multiple partners, one came from an endemic country, and two were intravenous (IV) drug users. Ages ranged from 22 to 50 (mean, 38) years.
RESULTS
Patients and Pathologic Characteristics
Pathologic examination was performed by members of the "French Study Group of Pathology for HIV-Associated Tumors." Tumors typed as IL or BL according to the international working formulation were selected for molecular analysis. All tumors were B-cell lymphomas, according to immunologic studies performed on frozen sections using monoclonal antibodies to detect B-cell antigens and Ig heavy and light chains (data not shown). Seven tumors (cases 1 through 7) were diagnosed as small noncleaved cell lymphoma of Burkitt type. Six tumors were IL, of which 5 (cases 9 through 13) showed marked plasmacytic differentiation. One sample (case 14) was typed as lymphoproliferation with plasmacytic differentiation (LP) according to the initial description of Nalesnik et alZZ in posttransplant lymphoproliferative diseases. Case 8 was diagnosed as intermediate between IL and BL. This tumor possessed features of small noncleaved cell lymphoma of the Burkitt type. The architecture was composed mainly of large cells with interspersed macrophages, giving rise to a "starry sky" pattern. A high level of apoptosis and a strong cohesiveness of the cells were observed. However, there was a polymorphism in the size ofthe tumor cells with presence ofan important percentage of small cells (Fig 2) . Most of the large cells possessed a large unique nucleolus, as seen in IL in contrast to the multiple and paracentral nucleoli of the small cells.
The majority of the cases had a nodal presentation. Extranodal presentation was observed in 5 patients: I had a subcutaneous mass, 3 had buccal involvement, and 1 had splenomegaly. Four patients had bone marrow (BM) involvement at diagnosis ( 
Detection of myc Rearrangements
In eight tumors, we identified rearrangements within the c-myc gene (Fig 3A) Because genetic polymorphisms in the c-myc gene are extremely rare, we interpret these as a result of chromosomal rearrangements. In case 9, with a diagnosis of IL, a faint rearranged c-myc fragment was observed. Therefore, the Southern analysis was repeated using EcoRI and HindIII, confirming the initial result (Fig 3B) . In one tumor classified as BL, a rearrangement on chromosome 8 could neither be detected by Southern blotting using a c-myc, pvt-1 or bvr-1 probe, nor using a probe detecting rearrangements in the region carrying a cluster of t (8;14) translocation breakpoints at a distance 175 kb 5' of cmyc. 39, 42, 43 The failure to detect all Burkitt translocations by conventional Southern blotting is consistent with the findings that the breakpoints can be scattered over a distance of more than 700 kb.39,46
Chromosome 14 Breakpoints Breakpoints were assumed to be located within the switch p region if two criteria were fulfilled: (1) hybridization of the JH and C p probes to different EcoRI and BamHI fragments indicating a noncontiguous configuration of JH and C p , and (2) comigration of fragments visualized by a Cp and a c-myc exon 3 probe after digestion with BamH1, EcoRI, and Hir~dII1.~' According to these criteria, 3 of the 8 cases with c-myc gene rearrangement (cases 2,5, and 9) had a breakpoint within the p switch region ( Table 2) .
JH. In two cases (cases 4 and 8) C p and JH probes hybridized to identical BamHI and EcoRI fragments, indicating a contiguous configuration of JH, Sp, and Cp on both alleles. However, hybridization with JH showed a third fragment different in size from the nonrearranged JH gene provided by the stromal cells. This third rearranged JH fragment did not hybridize to a Cp probe. Visualization of a third fragment was taken as an indication that the joining region is transected on one of both Ig heavy-chain alleles4' (Fig 4) . The most likely explanation is that one heavy chain is functionally rearranged and that the other is fused to chromosome 8 sequences within the region covered by the JH probe.
Breakpoints in the IgH gene locus of the three other tumors could not be localized by this method (Table 2) In contrast, polyclonal proliferations are composed of neoplastic cells carrying different Ig rearrangements. Each is expected to give a discrete band but the signal is too weak to be identified, and in fact nothing but the germline band can be identified by Southern blot analysis. Using the C p and the JH probes and at least two enzymes, all BL were monoclonal, whereas IL or LP were composed of monoclonal or polyclonal proliferations (Table 3 ). The Southern blot hybridization of two polyclonal proliferations using three different enzymes and the Cp and JH and J K probes is presented in Fig 5. 
Presence of EB V Sequences
The presence of EBV was detected in all cases of IL and LP and in 4 of 7 BL using the BamHI-W and the 1.9-kb XhoI probe (Table 3 ). The intensity of the signals obtained after hybridization was higher in monoclonal, than in polyclonal cases (Fig 6) with the exception ofcase 4 (not shown). For the three polyclonal cases, comparison with a cell line containing two copies of EBV DNA (Namalwa) indicated the presence of about one to two copies per cell.
Fusion of the terminal repeats gives rise to the episomal conformation of the EBV genome in lymphoid tumors. The number of terminal repeats, and thus the size of the fused terminal fragment, is variable in different infected cells. Southern blot hybridization using the 1.9-kb Xho I probe has been used to study the clonality of EBV-carrying tum o r~.~~ A single fused terminal fragment is interpreted as evidence for monoclonality, the presence of two or more terminal fragments is taken as evidence for oligoclonality or p~I y c I o n a I i t y .~~.~~-~' Seven of the 8 monoclonal proliferations were monoclonal according to the criteria described above (Fig 6A) . However, one case (case l , Fig 6B) showed one or two additional bands after digestion with BamHI, HindIII, and Xba I. The monoclonality ofthis case is beyond any doubt. The molecular analysis of Ig and c-myc rearrangement was performed on an established cell line and clearly showed monoclonality. Therefore, the detection of more than one band with the terminal-repeat probe is not definitely conclusive for oligoclonality or polyclonality (see also Discussion).
In one of the cases with polyclonal proliferation as defined by Ig gene rearrangement, oligoclonality or polyclonality was confirmed using the EBV terminal repeat probe and the restriction enzymes BamHI and EcoRI (case 14, Fig  6C) . The restriction enzyme HindIII generates very large fragments spanning the termini that cannot be resolved by conventional electrophoresis in case of polyclonality. All other cases showed one major band on the background of a smear, as exemplified for case 12 in Fig 6C. This type of pattern is not conclusive for either monoclonality or polyclonality, as detailed in the Discussion. Therefore, diagnosis of monoclonality or polyclonality is based on the unequivocal results obtained by the analysis of Ig gene rearrangements. Among the 14 tumors studied here, 7 had the characteristic morphologic features of BL. All 7 tumors were of monoclonal origin; 6 showed a c-myc rearrangement and 4 harbored EBV DNA sequences. Case 1 was clearly monoclonal with regard to Ig and c-myc rearrangements. However, it showed more than one band after hybridization with the l .9-kb Xho I probe. This shows that additional bands detected by this probe have to be interpreted with caution. They are not indicative for oligoclonality or polyclonality per se. There is a number of reasons why monoclonal tumors may harbor more than one EBV-terminal fragment. One obvious reason is the coexistence of episomal and integrated copies as recently reported for Burkitt's lymphoma cells.57 Another possibility that is difficult or impossible to exclude is homologous recombination among individual episomal genomes. Finally, reinfection of cells carrying already EBV genomes has been reported to occur in vitro."
Our data confirm previous studies showing the presence of EBV in about one-half of the BL cases in HIV+ individu a l~' *~~* " (Table 3 ). Remarkably, neither ofthe patients with BL presented with opportunistic infections or Kaposi sarcoma at the time of diagnosis (Table 3 ). This is in line with the observation of Kalter et a13 that BL is often an early or even the first manifestation of AIDS.
Four of 6 lymphomas with morphologic features of IL as well as the case diagnosed as lymphoproliferation were associated with EBV and were devoid of c-myc rearrangement. Three of them were polyclonal and 2 were monoclonal according to the analyses of the Ig gene rearrangements. The polyclonal cases exhibited a comparatively small number of viral genome copies per cell and it remains an open question as to whether in fact all cells camed the viral DNA within the pathologic lesions. However, even if the EBV load is low in these lymphoproliferations compared with the monoclonal cases including EBV+ Burkitt lymphomas, the detection of viral sequences within a clinical specimen by conventional Southern blotting is indicative of an EBV-associated lymphoproliferation. In 50 HIV+ patients with persistent generalized lymphadenopathy, it has not been possible to detect EBV by conventional Southern bl~tting.~' EBV has only been detected in persistent generalized lymphadenopathy from HIV-infected patients by polymerase chain reaction (PCR).@ Clonality was studied not only by Ig gene rearrangement analyses, but also using an EBV terminal repeats specific probe. Analyses oftwo ofthe polyclonal cases with the terminal repeat probe of EBV showed a smear with one band predominating (Fig 6C) . At first sight, this suggested the presence of a minor occult clonal population within the polyclonal lymphoproliferations that remained undetected by Ig gene rearrangement analysis. However, this conclusion is unlikely to be correct for the following reasons. Herpes viruses carry quite variable numbers of terminal repeats at the ends of their linear viral genome. However, the variation in terminal repeat copy number is much smaller if the number of terminal repeats from the left and right end of individual linear DNA molecules is compiled.6'.62 The reason is probably that only DNA molecules within a given range of length can be packaged. Circular genomes contain the terminal repeats from both ends. Therefore, the number of repeats is less variable than the number of repeats from individual ends. Because the number of repeats follows a Poisson distribution, molecules with an average number of repeats will predominate. This is exactly what has been observed by us and others, ie, a minor band in the middle o f a smear (Fig 6C) .50 Therefore, the existence of a band on the background of an homogeneously distributed smear cannot be taken as definite evidence for the existence of an occult clonal population, even though this interpretation has been proposed and cannot be formally ruled out." Asa result, the analysis of Ig gene rearrangements is more reliable and remains the method of choice.
The two monoclonal cases of IL developed in highly immunosuppressed patients: case 10 occurred in a patient with AIDS symptoms, whereas the other monoclonal case occurred in a patient with an extremely low count of CD4" peripheral blood lymphocytes (33/mm3). The two polyclonal IL cases and the case of lymphoproliferation (case 14) are very similar to lymphoproliferations in transplant recipients in which EBV-infected B cells proliferate in vivo, as a consequence of severe immunosuppression.
Two lymphomas associated with EBV and typed as IL possessed rearrangements of the c-myc gene. These rearrangements were confirmed using several enzymes excluding a restriction polymorphism. One case was composed of immunoblastic cells, whereas the other was composed of a tumor sharing features of BL and IL. The development of this tumor was preceded by a generalized reactive lymphadenopathy, as often reported for BL.'.' These two lymphomas were the only tumors with a rearranged c-myc gene that appeared in patients with extremely advanced immunodepression (Table 3) .
Only few large studies have investigated the presence of chromosomal translocations and/or c-myc rearrangement in immunoblastic lymphomas in the nonimmunosup pressed population. The overall frequency of t(8; 14) (q24;q32) translocations in IL was reported to be 1 in 42 cases at the Fifth International Workshop on Chromosomes in Leukemias and lymphoma^,'^ although two reports in the literature described higher f r e q u e n~i e s .~~.~ No data were presented on the HIV status of these cases. Within a large series of diffuse large-cell lymphomas for which karyotypic as well as c-myc rearrangement data were available, two cases of immunoblastic B-cell lymphomas with t(8;14) translocations and c-myc rearrangement were de~cribed.~' Of these, one arose in an HIV-infected individual. For the second, the HIV status was not presented. Furthermore, association with EBV has not been studied. Another case of an immunoblastic lymphoma with c-myc rearrangement and associated with EBV was described in an AIDS patient. 31 Taking into account the additional two cases of monoclonal immunoblastic lymphomas with c-myc rearrangement presented here, we may conclude that immunoblastic lymphomas with c-myc rearrangement can be detected to a small although significant percentage in HIV+ individuals, but are exceptional outside the context of HIV infection.
Two hypothesis can be proposed to explain the pathogene- Thus, we hypothesize that the two EBV+ tumors with a c-myc rearrangement have adopted morphologic features of IL caused by the severe perturbation of the immune system in these patients. Immunohistologic analyses are in progress to correlate the morphologic features of these tumors with the pattern of cell-surface antigen as well as viral-gene expression. Another interesting correlation has recently been observed between morphology and interleukin-6 (IL-6) expression in lymphomas that had developed in HIV seropositive and negative patients." A high number of IL-6 producing stromal cells has been observed in IL but not in BL. Remarkably, the case with a morphology intermediate between IL and BL reported here has been included in this study and was found to harbor a high number of IL-6-expressing cells. This raises the question as to whether IL-6 is responsible for morphologic transformation towards immunoblasts. IL-6 receptor has been reported to be expressed in immunoblasts. It will also be interesting to see whether EBV can modulate expression of this receptor.
